KRT17 antibody (C-Term)
Quick Overview for KRT17 antibody (C-Term) (ABIN7184791)
Target
See all KRT17 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Cross-Reactivity
- Human, Mouse, Rat
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from the C-terminal region of Human Cytokeratin 17.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB:1:500-1:2000, IHC:1:100-1:300, IF:1:200-1:1000, ELISA:1:20000,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- KRT17 (Keratin 17 (KRT17))
-
Alternative Name
- KRT17
-
Background
- 39.1 antibody, CK 17 antibody, CK-17 antibody, Cytokeratin-17 antibody, K17 antibody, K1C17_HUMAN antibody, Keratin 17 antibody, keratin 17 epitope S1 antibody, keratin 17 epitope S2 antibody, keratin 17 epitope S4 antibody, Keratin 17, type I antibody, Keratin antibody, Keratin type I cytoskeletal 17 antibody, keratin, type i cytoskeletal 17 [version 1] antibody, Keratin-17 antibody, KRT17 antibody, PC antibody, PC2 antibody, PCHC1 antibody, type I cytoskeletal 17 antibody
-
UniProt
- Q04695
Target
-